A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer

This study is ongoing, but not recruiting participants.

Study NCT00661609 Information provided by AstraZeneca

First Received: April 16, 2008 Last Updated: April 30, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2009
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)